Trial Outcomes & Findings for A Biomarker Stress Test for Detection of Early Osteoarthritis (NCT NCT02593864)
NCT ID: NCT02593864
Last Updated: 2020-11-20
Results Overview
Knee adduction moment describes the medial/lateral load distribution of the knee measured while walking in a gait laboratory. Before normalization to account for size, the knee adduction moment is expressed in Nm. However, to account for different sized people, the knee adduction moment is transformed and expressed in percentage of body weight times height (%BW\*ht). Higher knee adduction moments have been linked to more severe osteoarthritis (OA). Knee adduction moment will be analyzed at baseline and after 6 months of variable-stiffness shoe wear. Values at 6 months (in variable-stiffness shoe) will be compared to baseline (in control shoe).
COMPLETED
NA
25 participants
Baseline to 6 months
2020-11-20
Participant Flow
X-ray screening for inclusion/exclusion criteria
Participant milestones
| Measure |
Variable-Stiffness Shoe
Subjects will wear a load-modifying variable-stiffness shoe for 6 months
Variable-Stiffness Shoe: A load-modifying variable-stiffness shoe previously shown to reduce joint loading
|
|---|---|
|
Overall Study
STARTED
|
25
|
|
Overall Study
COMPLETED
|
19
|
|
Overall Study
NOT COMPLETED
|
6
|
Reasons for withdrawal
| Measure |
Variable-Stiffness Shoe
Subjects will wear a load-modifying variable-stiffness shoe for 6 months
Variable-Stiffness Shoe: A load-modifying variable-stiffness shoe previously shown to reduce joint loading
|
|---|---|
|
Overall Study
Withdrawal by Subject
|
3
|
|
Overall Study
Lost to Follow-up
|
3
|
Baseline Characteristics
Per protocol cohort. Baseline value of subjects who completed the 6 month study visit. Gait data unusable for 1 subject at follow-up, and this subject was not included in the baseline value.
Baseline characteristics by cohort
| Measure |
Variable-Stiffness Shoe
n=25 Participants
Subjects will wear a load-modifying variable-stiffness shoe for 6 months
Variable-Stiffness Shoe: A load-modifying variable-stiffness shoe previously shown to reduce joint loading
|
|---|---|
|
Age, Continuous
|
58.6 years
STANDARD_DEVIATION 10.9 • n=25 Participants
|
|
Sex: Female, Male
Female
|
8 Participants
n=25 Participants
|
|
Sex: Female, Male
Male
|
17 Participants
n=25 Participants
|
|
Race (NIH/OMB)
American Indian or Alaska Native
|
0 Participants
n=25 Participants
|
|
Race (NIH/OMB)
Asian
|
3 Participants
n=25 Participants
|
|
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
|
0 Participants
n=25 Participants
|
|
Race (NIH/OMB)
Black or African American
|
3 Participants
n=25 Participants
|
|
Race (NIH/OMB)
White
|
18 Participants
n=25 Participants
|
|
Race (NIH/OMB)
More than one race
|
1 Participants
n=25 Participants
|
|
Race (NIH/OMB)
Unknown or Not Reported
|
0 Participants
n=25 Participants
|
|
Region of Enrollment
United States
|
25 participants
n=25 Participants
|
|
Knee Adduction Moment
|
2.67 %Bw*Ht
STANDARD_DEVIATION 0.76 • n=18 Participants • Per protocol cohort. Baseline value of subjects who completed the 6 month study visit. Gait data unusable for 1 subject at follow-up, and this subject was not included in the baseline value.
|
|
COMP at 3.5 Hours (% Of Baseline Resting)
|
84.4 % Of Resting
STANDARD_DEVIATION 11.1 • n=15 Participants • Per protocol cohort. These analyses are based on available data from 15 subjects who completed both the baseline and follow-up visits for analysis of changes in COMP. Biomarker data for one subject was missing at baseline, and complete biomarker data for 3 subjects was unable to be collected at follow-up.
|
PRIMARY outcome
Timeframe: Baseline to 6 monthsPopulation: These results were based on gait data for 18 subjects that was available at both the baseline and follow-up visits
Knee adduction moment describes the medial/lateral load distribution of the knee measured while walking in a gait laboratory. Before normalization to account for size, the knee adduction moment is expressed in Nm. However, to account for different sized people, the knee adduction moment is transformed and expressed in percentage of body weight times height (%BW\*ht). Higher knee adduction moments have been linked to more severe osteoarthritis (OA). Knee adduction moment will be analyzed at baseline and after 6 months of variable-stiffness shoe wear. Values at 6 months (in variable-stiffness shoe) will be compared to baseline (in control shoe).
Outcome measures
| Measure |
Variable-Stiffness Shoe
n=18 Participants
Subjects will wear a load-modifying variable-stiffness shoe for 6 months
Variable-Stiffness Shoe: A load-modifying variable-stiffness shoe previously shown to reduce joint loading
|
|---|---|
|
Change at 6 Months From Baseline in First Peak Knee Adduction Moment (KAM): (6 Month Value - Baseline)
|
-0.19 %Bw*Ht
Standard Deviation 0.17
|
PRIMARY outcome
Timeframe: Baseline to 6 monthsPopulation: These analyses were based on available data from 15 subjects at both the baseline and follow-up visits for analysis of changes in COMP
Serum samples were collected before and after a 30 minute walking activity. Levels of serum cartilage oligomeric matrix protein (COMP) 3.5 hours following the 30-minute walk, expressed as a percentage of pre-activity resting values, were assessed, and values at 6 months were compared to baseline.
Outcome measures
| Measure |
Variable-Stiffness Shoe
n=15 Participants
Subjects will wear a load-modifying variable-stiffness shoe for 6 months
Variable-Stiffness Shoe: A load-modifying variable-stiffness shoe previously shown to reduce joint loading
|
|---|---|
|
Change at 6 Months From Baseline in Serum COMP Biomarker Levels in Response to a Mechanical Stimulus (6 Month - Baseline)
|
-0.8 Percent of Resting
Standard Deviation 10.3
|
Adverse Events
Variable-Stiffness Shoe
Serious adverse events
Adverse event data not reported
Other adverse events
| Measure |
Variable-Stiffness Shoe
n=25 participants at risk
Subjects will wear a load-modifying variable-stiffness shoe for 6 months
Variable-Stiffness Shoe: A load-modifying variable-stiffness shoe previously shown to reduce joint loading
|
|---|---|
|
Musculoskeletal and connective tissue disorders
Joint paint
|
28.0%
7/25 • Number of events 8 • 6 Months
|
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place